MYC and breast cancer: Furthermore, less cell proliferation in CD133-high BC may explain better prognosis, going along with some prior findings that showed an association between more expression of genes related to proliferation such as G2M [26–27], E2F [23, 25], and MYC [64] and worse prognosis in ER+/HER2− BC.